Prevalence of and risk factors for primary open-angle glaucoma in central Sri Lanka: the Kandy eye study

Ophthalmic Epidemiology
David I T SiaR J Casson

Abstract

To report the prevalence and risk factors associated with primary open-angle glaucoma (POAG) in the Kandy district of central Sri Lanka. A cross-sectional, population-based ophthalmic survey of the inhabitants >or= 40 years of age from villages in the Kandy District, Sri Lanka was conducted. Selection was randomized using a cluster sampling process; 1721 eligible participants were identified, 1375 participated in the study and sufficient examination data to diagnose glaucoma in at least one eye was obtained in 1244 participants. A detailed ophthalmic history and examination including ocular biometry was made of each participant. Primary open-angle glaucoma was classified into three levels according to diagnostic evidence. The overall prevalence of POAG was 2.3% (95% CI 1.5-3.2). In the univariate analyses, increasing age (P = 0.001), intraocular pressure (IOP) (P < 0.001), myopia (P < 0.001) and axial length (P = 0.003) were significantly associated with POAG. In the multivariate analysis, age (P = 0.001), mean IOP (P < 0.001) and mean axial length (P = 0.008) were significant risk factors of POAG. The prevalence of POAG in the population aged >or=40 years in central Sri Lanka was 2.3%. POAG in this population was independently...Continue Reading

References

Jul 17, 1991·JAMA : the Journal of the American Medical Association·J M TielschJ Javitt
Apr 1, 1981·Archives of Ophthalmology·H A QuigleyA E Maumenee
Jun 1, 1994·Archives of Ophthalmology·M C LeskeL Hyman
Jul 12, 2001·American Journal of Epidemiology·C A HulsmanP T de Jong
Aug 21, 2003·The British Journal of Ophthalmology·R R A BourneP Rojanapongpun
Nov 19, 2004·The British Journal of Ophthalmology·M M RahmanG J Johnson
Nov 24, 2005·Investigative Ophthalmology & Visual Science·Lingam VijayaCatherine McCarty
Feb 21, 2006·The British Journal of Ophthalmology·H A Quigley, A T Broman
Jul 11, 2006·Ophthalmology·Yasuyuki SuzukiUNKNOWN Tajimi Study Group
Sep 28, 2006·Investigative Ophthalmology & Visual Science·Alicja R RudnickaDeborah Ashby
May 19, 2007·The British Journal of Ophthalmology·R J CassonT Aung
Jul 7, 2007·Ophthalmic Epidemiology·Jae H KangLouis R Pasquale
Sep 27, 2007·Ophthalmic Epidemiology·M Cristina Leske
Nov 14, 2007·Clinical & Experimental Ophthalmology·Robert J CassonThan Aung
Apr 29, 2008·Investigative Ophthalmology & Visual Science·Sunny Y ShenTin Aung
Aug 21, 2009·BMC Ophthalmology·Silvana Artioli SchelliniCarlos Roberto Padovani

❮ Previous
Next ❯

Citations

Feb 6, 2014·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Hua LiSheng-Fang Song
May 20, 2014·Survey of Ophthalmology·Hyun-Kyung Cho, Changwon Kee
Jun 27, 2015·The British Journal of Ophthalmology·Errol Wei'en ChanChing-Yu Cheng
Jan 30, 2013·Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye·Jean-Claude MwanzaDonald L Budenz
Mar 18, 2015·Ophthalmic Epidemiology·Fatima KyariUNKNOWN Nigeria National Blindness and Visual Impairment Study Group
Jun 9, 2016·BMC Ophthalmology·Fatima KyariUNKNOWN Nigeria National Blindness and Visual Impairment Study Group
Jan 8, 2015·Current Opinion in Ophthalmology·Chi-Hsin HsuShan C Lin
Mar 20, 2021·The British Journal of Ophthalmology·Brad GuoRobert J Casson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.